General
Preferred name
Tofogliflozin (hydrate)
Synonyms
TOFOGLIFLOZIN HYDRATE ()
CSG-452 hydrate ()
Tofogliflozin(CSG 452) ()
TOFOGLIFLOZIN ()
Tofogliflozina ()
Tofogliflozin hydrate ()
Tofogliflozine ()
Tofogliflozin monohydrate ()
CSG452 ()
Tofogliflozin ()
P&D ID
PD076456
CAS
1201913-82-7
Tags
available
drug
Drug Status
approved
Max Phase
4.0
Drug indication
Non-alcoholic steatohepatitis
First approval
2014
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Tofogliflozin hydrate (CSG-452 hydrate) is a potent and highly specific sodium/glucose cotransporter 2 (SGLT2) inhibitor with an IC50 of 2.9 nM and Ki values of 2.9 nM, 14.9 nM, and 6.4 nM for human, rat, and mouse SGLT2[1]. Tofogliflozin partially inhibits high glucose-induced reactive oxyen species (ROS) generation in tubular cells[2].
PRICE
122
DESCRIPTION
Tofogliflozin hydrate (CSG-452 hydrate) is a potent and highly specific inhibitor of SGLT2, with an IC50 of 2.9 nM and Ki values of 2.9 nM, 14.9 nM, and 6.4 nM for human, rat, and mouse SGLT2, respectively.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
7
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
EU-OPENSCREEN Bioactive Compound Library
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
10
Molecular Weight
404.18
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
4
Rotatable Bonds
4
Ring Count
4
Aromatic Ring Count
2
cLogP
0.17
TPSA
130.88
Fraction CSP3
0.45
Chiral centers
5.0
Largest ring
6.0
QED
0.57
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Reactive Oxygen Species
ROS
SGLT
SGLT2
Reactive Oxygen Species (ROS)
Pathway
NF-¦ÊB
GPCR/G protein
Immunology/Inflammation
Metabolism
NF-κB
Membrane Transporter/Ion Channel
Metabolic Enzyme/Protease
Source data

